Medical device structural adhesives market seen reaching $2.55B by 2030

The medical device structural adhesives market is projected to grow from $1.6 billion in 2025 to $2.55 billion by 2030, driven by demand for smaller, more durable devices and higher use of advanced biocompatible adhesives. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Medical device structural adhesives help manufacturers bond complex materials securely, supporting device performance, fluid-tight sealing, and patient safety. - The market outlook points to steady demand from minimally invasive devices, wearables, connected devices, and implantable technologies. - Faster growth in Asia-Pacific suggests production and healthcare investment are shifting beyond traditional U.S. and European centers.

What happened: - The Business Research Company said the medical device structural adhesives market will rise from $1.6 billion in 2025 to $1.75 billion in 2026. - The report projects the market will reach $2.55 billion by 2030. - The forecast implies a 9.6% CAGR from 2025 to 2026 and a 9.8% CAGR through 2030. - The company published the findings in its "Medical Device Structural Adhesives Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report includes a free sample and a full market report available online via sample request and the full report.

The details: - Medical device structural adhesives are high-performance bonding agents designed to permanently join different materials during medical device assembly. - The adhesives are biocompatible and built to retain bond strength through sterilization processes. - Key uses include diagnostic tools, surgical instruments, implantable devices, drug delivery systems, and wearable health monitors. - The adhesives are designed to maintain structural integrity and fluid-tight sealing. - Growth has been supported by rising use of minimally invasive medical technologies, stronger device assembly requirements, and more frequent combinations of polymer and metal parts. - The report says demand is also rising for smaller and lighter devices, automated adhesive application, sterilization-resistant products, low-outgassing formulations, fast-curing products, and bonding across different substrates. - The FDA recorded an increase in Breakthrough Devices granted marketing approval from 179 in 2025 to 198 in 2026. - FDA Breakthrough Device designations rose from 1,179 to 1,284 in the same period.

Between the lines: - The forecast suggests medical device makers are prioritizing reliability and manufacturability as products become smaller and more complex. - Growing interest in connected and wearable devices points to adhesives becoming a more critical enabling material, not just a back-end assembly input. - The FDA figures show innovation activity is still accelerating, which should keep pressure on materials suppliers to deliver specialized bonding performance.

What's next: - North America is expected to remain the largest market, supported by its established healthcare infrastructure and medical device manufacturing base. - Asia-Pacific is projected to post the fastest growth over the forecast period as healthcare investment, innovative device adoption, and industrialization expand. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - The Business Research Company said its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - More information is available from the company at www.thebusinessresearchcompany.com.